The effectiveness of China's leprosy programme China's control methods of repeated case-finding surveys, replacing Missionary hospitals with Government hospitals staffed by Chinese doctors, and financial assistance from the Government for all leprosy patients since 1950, have produced laudable results. Of the accumulated 500,000 leprosy patients from 1957 to 1988, only 14% are now classified as active cases. Since 1957, 10 provinces (one-third) in the North and North-East of China have achieved the goal of 'basic eradication', i.e. a prevalence rate ofless than 0·01 per 1,000, and an incidence rate of less than 0·02 per 100,000. The prevalence of leprosy in children under 15 years of age has fallen from 16% of all leprosy patients in 1957 to 0·06% of all patients in 1986. Virtually all this has been accomplished using dapsone monotherapy.
Despite the remarkable effectiveness of incidence and prevalence control measures, the effectiveness of continuing care, including the prevention of deformities among the accumulated half a million patients, provides a marked contrast. While the 50 patients with disabilities that I examined came from leprosy villages or the Centre's clinical department and were mostly of the more severe fo rms of leprosy, they were also the only patients who could be supervised every day. On average, disability or deformity occurred 6 years after the diagnosis of leprosy and 70% of the disabilities were Grade 3, using the WHO scale.4 On direct questioning, only half the patients said they inspected their anaesthetic areas daily, while only a third exercised their nerve-damaged eyes, hands or fe et. None of the patients had special shoes, protective gloves or glasses for their anaesthetic and unprotected disabilities, although 10 patients had had reconstructive operations or amputations.
The worrying aspect of the above is that while China's Leprosy Centre and the leprosy service generally have the organizational skills, manpower, and the Government backing to reduce incidence and prevalence of leprosy, they seem to be lacking in the incentive to prevent and treat deformity among 'cured' patients. This is all the more regrettable since the technology to do so is in fact available.5.6
Lessons to be learnt
The disability data in the People's Republic of China, if eventually collected, will show a sad trend.
Rehabilitation as a specialty in China began only in the I 980s--decades after America-but, even today, it attracts little enthusiasm as a medical subject among the younger doctors.
The current plan is to build 10 rehabilitation centres; 2 by 1990, which will: I, research into rehabilitation; 2, retrain 2000 doctors in rehabilitation; and 3, educate patients with Grade 2 disability every 3-6 months. There are, however, grounds for questioning the need for special centres and even the need for doctors in teaching 'self-care'. Workers drawn from leprosy patients themselves, and medical workers like 'community physiotherapists' may be better suited to the job of visiting patients every month (or seeing the patients in clinics), and perhaps organizing a County 'Self-Care' day every 6 months for all patients. Motivation could be enhanced by financial bonuses to workers whose patients' deformities have not worsened during the preceding 6 months.
Perhaps the above is impractical but, either as a result of steady improvement in socioeconomic conditions and/or the application of medical measures (essentially dapsone monotherapy), highly significant reductions in incidence and prevalence have been achieved in the People's Republic of China. It is to be hoped that disability control will make similar progress. The basic organization already exists and in a country with such able and highly motivated people, where so much has been achieved in 'bacillus control', it should be possible to tackle 'disability control' with equal success.
